Showing posts with label Complex Regional Pain Syndrome. Show all posts
Showing posts with label Complex Regional Pain Syndrome. Show all posts

Saturday, March 27, 2010

Complex Regional Pain Syndrome (CRPS)


Synonyms:
Reflex sympethatic Dystrophy Syndrome (RSDS), Sudeck's Atrophy, Causalgia, Shoulder-Hand Syndrome, Posttraumatic Dystrophy, Sympathetic maintained pain syndrome
History:

  • Recognized since the Civil War when it was called causalgia, a name chosen to describe intense, burning extremity pain after an injury.

  • Bonica coined the term reflex sympathetic dystrophy in 1953
Incidence:

1% of all conservatively treated distal radius fractures and up to 5% of operatively treated fractures.
Types:

  • CRPS type I

    • secondary to an identifiable neurologic compression or injury.

    • e.g. ulnar nerve axonotemesis or a superficial radial nerve injury due to trauma from an external fixator pin.

  • CRPS type II

    • no identifiable neurological injury

    • sympathetically mediated pain
Stages:
Acute:

  • 6-12 wks

  • persistent burning pain

  • trivial injury followed by severe & out of proportion pain

  • Localised pain, later spreads throughout extremity

  • Hypersensitivity to light touch

  • Extremity swollen & warm

  • Excessive perspiration

Dystrophic

  • Affected joint ROM restricted

  • Involved area becomes cool
Atrophic

  • Skin & muscle atrophy

  • Skin dry, shiny, glossy

  • Stiffness, intractable pain persists several weeks
Diagnosis:

  • Identify for CRPS type I or CRPS type II.

  • determine if it is a treatable source (type I).

  • Persistent burning pain after an injury is characteristic.

  • most common lesion with type I is median nerve injury, due to direct trauma or an undiagnosed compressive neuropathy.

  • causes are injury to the ulnar nerve, the superficial radial nerve, the intercarpal ligament, or the triangular fibrocartilage.

  • delayed union, incomplete union, and nonunion may also contribute to symptoms.

  • X-ray – Patchy Osteoporosis

  • Peripheral nerve conduction studies e.g. compression points around the elbow are useful, also evaluate the ulnar nerve.

  • MRI may show an incomplete union, carpal injuries, or TFCC injury.

  • Arthroscopic reveal arthrofibrosis and/or TFCC injuries.

  • Bone Scan +ve, showing regional uptake reflects ncreased blood flow
Treatment:

  • Prevention, immediate attention, control pain & swelling.

  • Restoration of motion by exercise

  • Active use of extremity despite pain

  • Edema control by limb elevation

  • Physiotherapy

  • Drugs: antidepressants, corticosteroids, calcium channel blockers
CRPS Type I:
Surgical treatment:

  • Neurolysis aimed at external compression of the median and ulnar nerve injuries.

  • Adjunctive grafting or Barrier wrapping for injury to sensory branches of the superficial radial or dorsal ulnar nerve.

  • Neuroma resection proximally and nerve stump can be buried in appropriate soft tissue.

  • External bone stimulators or revision osteosynthesis for an incomplete union.
CRPS type II

  • Multifaceted, aimed at restoring ANS control and improving physical function.

  • Early recognition and regional blockade with physical therapy is useful.
Medical management

  • guided by the appearance of the hand and wrist (Early phases marked by erythema and swelling, later phases, they may appear cool and atrophic.

  • For warm, swollen erythematous hand, treatment include gabapentin, selective serotonin reuptake inhibitors, or clonidine hydrochloride.

  • In later stages, the aim is to improve blood flow, using nifedipine or selective serotonin reuptake inhibitors.
Physical therapy

  • mobilizing the wrist and digits.

  • Focus is to improve wrist extension, causing greater mechanical advantage.

  • Adjunctive modalities such as dynamic or serial static splinting may prove effective at mobilizing the wrist and the metacarpophalangeal joints.
Prognosis

  • Recovery after CRPS treatment varies.

  • the prognosis for CRPS type I is better than that of CRPS type II.

  • When the syndrome continues for more than 1 year, it is likely that residual impairment will be present.

  • Regardless of the treatment afforded, patients experience delayed recovery.